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Summary
SUMO (Small Ubiquitin-like MOdiﬁer) conjugation is a
post-translational modiﬁcation implicated in a variety
of cellular functions including transcriptional re-
gulation, nuclear location and signal transduction.
Sumoylation, although conserved and vital in eukary-
otes, has not been studied in malaria parasites.
Here, we identify SUMO conjugation of blood stage
parasites of Plasmodium falciparum. Antibodies
raised against synthetic peptides of the plasmodial
SUMO orthologue PfSUMO, a 100-amino-acid protein,
reacted with distinctive subcellular compartments
of the parasitized erythrocyte during blood stage
development. Anti-PfSUMO stains the nucleus and
parasite cytoplasm. We also found antibody reactivity
in the host cell cytoplasm with the parasite-derived
structures called Maurer’s clefts. Anti-PfSUMO reacts
in Western blot with a number of blood stage proteins
ranging from approximately 40–250 kDa. Parasites
expressing FLAG-tagged PfSUMO gave similar
results in Immunoﬂuorescence assay and Western
blots. In addition, we show that anti-PfSUMO identi-
ﬁed PfSir2, a telomere-associated nuclear protein
involved in var gene silencing, as a target for
sumoylation. Furthermore, LC-MS/MS analysis of a
two-step immunoprecipitation (IP) with anti-FLAG and
anti-PfSUMO antibodies reveals a number of putative
P. falciparum sumoylated proteins. Our results imply
that SUMO conjugation has an essential function
in a number of different biological processes in
P. falciparum.
Introduction
Gene expression in eukaryotes is executed by a relatively
small number of regulators, the dynamic prospects of
which are dramatically increased by post-translational
modiﬁcations. Reversible post-translational modiﬁcations
of proteins, such as phosphorylation, acetylation, methy-
lation and ubiquitination have critical roles in many cellular
processes owing to their ability to cause rapid changes
in functions of pre-existing proteins and subcellular
structures. Covalent attachment of one protein to another,
resulting in altered localization and/or function, is one of
the best-studied post-translational modiﬁcations with
respect to prevalence in eukaryotes. Among these, ubiq-
uitination is the most studied; however, other ubiquitin-like
proteins (Ubls), such as SUMO, Nedd 8 and ISGN15, are
gaining increased attention (Jentsch and Pyrowolakis,
2000).
Plasmodium falciparum, the most virulent of the proto-
zoan parasites infecting humans, causes a medically and
socio-economically debilitating form of malaria. Although
components of the ubiquitination pathway and related
ubiquitin-like modiﬁcation, such as neddylation has
been recently reported in malaria parasites (Artavanis-
Tsakonas et al., 2006), protein sumoylation in apicom-
plexan parasites has not been investigated. This, despite
the fact that SUMO is emerging as a ﬂexible modiﬁer for
a large number of proteins in many different pathways
with diverse consequences and targets (Seeler and
Dejean, 2003). SUMO is structurally related to ubiquitin
(Bayer et al., 1998), is of similar size and is also ligated to
lysine residues within its target proteins. This happens via
a cascade of activation, conjugation and ligation steps, to
produce an isopeptide bond between C-terminal glycine
of SUMO and a speciﬁc lysine (within a short consensus
sumoylation motif) of the target protein (Johnson, 2004).
However, unlike ubiquitin it does not mark the protein for
degradation, instead it modiﬁes its substrate’s interaction
with partner proteins. In contrast to the single SUMO
found in Saccharomyces cerevisiae, Drosophila melano-
gaster and Caenorhabditis elegans, higher eukaryotes
express multiple SUMOs, with up to eight members in
Arabidopsis thaliana and three in humans, namely
SUMO1, SUMO2 and SUMO3. Mature SUMO2 and
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stantially from SUMO1 (~50% identity).
The complex life cycle of the human malaria parasite
P. falciparum, divided between insect vector and human
host, necessitates dynamic protein expression and
gene regulation to exploit efficaciously the different host
environments. Clearly the parasite requires a dynamic
protein repertoire and a ubiquitous control of gene expres-
sion to achieve such complex tasks. This has been gen-
erally evidenced by reports of considerable levels of gene
expression regulation throughout the P. falciparum life
cycle (Florens et al., 2002; Lasonder et al., 2002). Fur-
thermore, the scarcity of plasmodial transcription regula-
tors identiﬁed (Coulson et al., 2004) indicates alternative
modes of control. A good example of a prominent role of
reversible post-translational modiﬁcations in gene regula-
tion comes from the study of histone marks and the telo-
meric chromatin-associated PfSir2 protein in antigenic
variation of P. falciparum (Freitas-Junior et al., 2005;
Chookajorn et al. 2007; Cui et al., 2007; Lopez-Rubio
et al., 2007). Here we demonstrate the presence of
another post-translational modiﬁcation in malaria para-
sites called sumoylation. We report data that imply a
crucial role of SUMO-conjugated proteins in different pro-
cesses during P. falciparum blood stage development.
Results
Identiﬁcation of P. falciparum SUMO1/SMT3 homologue
and sumoylation pathway components
Growing evidence of the presence and role of ubiquitin-
like modiﬁers in gene regulation in model eukaryotic
systems led us to search for putative Ubls in P. falciparum.
Amino acid sequence comparisons revealed a putative
Ubl catalogued with gene ID PFE0285c (previously
MAL5P1.58) in PlasmoDB as having the best score.
Based on the best-hit score we have hereby called it
PfSUMO. Multiple alignments with other previously char-
acterized SUMO orthologues show that PfSUMO is 46%
identical to S. cerevisiae SMT3, 40% identical to Human
SUMO1, Mouse SMT3 and S. pombe Pmt3 and 47% and
43% to Human SUMO2 and 3 respectively (Fig. 1A). To
exclude the possibility of obtaining a protein involved in
ubiquitination or some other Ubls instead, we carried out
similar alignment(s) with known yeast and human ubiq-
uitin, revealing only about 11% and 7% identity, respec-
tively, to PfSUMO (Fig. S1). Furthermore, PfSUMO lacks
the critical Lys48 and Lys63 residue of ubiquitin, required
for the generation of ubiquitin polymers and instead
seems to possess the most prominent feature of SUMO1,
a long N-terminus, which is believed to be highly ﬂexible
and protruding from the core of the protein (Bayer et al.,
1998). However, the two C-terminal Gly residues required
for isopeptide bond formation are conserved between all
sequences. These bioinformatic analyses and observa-
tions together suggest the protein to be of the SUMO
family. Interestingly, though it shares slightly more identity
to SUMO2, other features such as high similarity score
with S. cerevisiae SMT3 and apparent structural features
such as the long N-terminal point it to be more similar to
SUMO1.
The complete characterization of a protein involved in a
crucial process necessitates deciphering and establishing
its entire pathway. We thus carried out homology search
for enzymes involved in the SUMO pathway for yeast and
humans against the P. falciparum database. P. falciparum
orthologues of all members of the pathway have been
identiﬁed and the proposed pathway components are rep-
resented (Fig. 1B). Like its most widely known counterpart
SMT3, SUMO1 is conjugated to target proteins by a
pathway that is distinct from, but analogous to, the ubiq-
uitin conjugation. Similar to known SUMO E1 enzymes,
which are distinct from ubiquitin-speciﬁc enzymes
(Desterro et al., 1997; Johnson and Blobel, 1997),
P. falciparum E1 consists of a heterodimer of two
enzymes, Uba2 and Aos1. The E2 homologue with con-
jugating activity is the Ubc9, which also acts as the SUMO
ligase (Johnson and Blobel, 1997). The pathway is com-
pleted with the SUMO proteases, which have the dual
function of de-sumoylating the target by cleaving the sub-
strate bound SUMO peptide, as well as to process the
mature SUMO by cleaving it to leave the diglycine motif at
the terminus for isopeptide bond formation.
Detection of putative sumoylated proteins in
P. falciparum
Western blot analysis of P. falciparum total parasite
extracts was performed, revealing several bands corre-
sponding to potentially sumoylated plasmodial proteins
(Fig. 2). Anti-PfSUMO guinea pig sera stains a number
of different proteins within the range of ~40 kDa to
< 250 kDa in strain 3D7 parasite extracts. The pre-
immune sera did not recognize the large majority of
the proteins. Similar results were observed in extracts
from transfectants bearing endogenously FLAG-tagged
PfSUMO (Fig. 2). Mouse anti-FLAG antibody stains an
essentially comparable pattern in PfSUMO-FLAG trans-
fectants, although revealing a few more potentially
sumoylated proteins, perhaps due to higher sensitivity
resulting from tagging. In-depth analysis of the membrane
and cytosolic proteome of red blood cell did not reveal any
evidence of sumoylated proteins so far (Pasini et al.,
2006). Nevertheless, to exclude any host-speciﬁc sumoy-
lated proteins and conﬁrm speciﬁcity of the antibodies,
extracts from uninfected red blood cells were also blotted
with the above-mentioned antibodies (Fig. 2, right panel).
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stages, mature trophozoite and schizont stages, revealed
differential pattern (data not shown), indicating that the
modiﬁcation targets stage-speciﬁc proteins or modiﬁes
the same protein differentially in a stage-speciﬁc manner.
Kinetics and localization of sumoylated proteins in
infected red blood cells
To address the question as to where SUMO target pro-
teins localize, we performed immunoﬂuorescence assays
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Fig. 1. PfSUMO alignment with orthologous proteins. CLUSTAL W algorithm was used to ascertain PfSUMO homology to known SUMO
orthologues.
A. Multiple alignments between Mouse SMT3, Human SUMO1, 2 and 3, S. cerevisiae SMT3 and S. pombe Pmt3 was done. Dark shading
represents residues identical in all sequences. Light shading, residues similar between respective sequences. Box, conserved di-glycine motif.
Dashes, spaces inserted to achieve optimal match. Bold line above Pf sequence, most antigenic residues used to generate anti-peptide
antibodies.
B. Schematic of P. falciparum sumoylation pathway. P. falciparum orthologues for all members of the sumoylation pathway have been
identiﬁed. The C-terminus of a mature SUMO (PFE0285c) containing the glycine–glycine motif, is ﬁrst activated by activating enzyme E1, a
dimer of Uba 2 (PFL1790w) and Aos1 (PF11-0457), linking it by a thioester to a cysteine residue in Uba2. Activated SUMO is then transferred
to a cysteine residue of E2, a SUMO-speciﬁc conjugating enzyme Ubc9 (PFI0740c). In conjugation with SUMO ligases, Ubc9 conjugates
SUMO to various substrate proteins. Target proteins contain SUMO motifs, whereby the SUMO binds to a speciﬁc lysine residue. Sumoylated
substrates undergo de-conjugation via speciﬁc SUMO proteases, Ulp1(PFL1635w) and Ulp 2 (PFD 0970c). Another P. falciparum sumoylation
pathway developed by H. Ginsburg can be found: http://sites.huji.ac.il/malaria/maps/SUMOylation.html
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ciﬁc stages with anti-PfSUMO antibodies (Fig. 3A). Stain-
ing was observed in all the blood stages with a differing
pattern across the stages. Ring stage wild-type 3D7 para-
sites showed partial nuclear staining along with around
5–6 Maurer’s clefts-like vesicular structures in the host
cytoplasm. A similar pattern was observed during tro-
phozoite stages but the number of vesicular structures
increased (Fig. 3A, middle panel). At schizogony the
picture became more dense as diffused staining, mainly
throughout the nuclei, was observed (Fig. 3A, right panel).
SUMO modiﬁcation in other systems is known to target
mainly nuclear proteins, although many reports implicate
SUMO in modifying cytosolic proteins speciﬁcally target-
ing nuclear-cytosolic export. Furthermore, the pattern
appeared to be similar to the P. falciparum Maurer’s clefts,
vesicle-like structures that are involved in the trafficking of
PfEMP1 and other virulence proteins to the host cell
surface. IFAs on PfSUMO-FLAG transfectants yielded
similar staining pattern throughout the life cycle when
probed with anti-FLAG antibody, with the exception of the
Maurer’s clefts-like pattern not being detectable in most
parasites analysed (Fig. 3B). A minority (approximately
1%) of the PfSUMO-FLAG-infected parasites, when
assayed with anti-FLAG antibodies did, however, show
the host cytosolic staining (Fig. 3C). This may be
explained by altered characteristics of the tagged
PfSUMO.
However, intrigued by the Maurer’s clefts-like staining
by PfSUMO sera, we undertook colocalization IFAs with
P. falciparum markers staining speciﬁc parasite compart-
ments and anti-PfSUMO antibodies (Fig. 4). To this end,
we used anti-PfSir2 (Freitas-Junior et al., 2005), a nuclear
marker, and observed partial colocalization of PfSUMO
with the peripheral nuclear staining pattern of PfSir2. This
demonstrated the nuclear staining by anti-PfSUMO and
is consistent with a possible association with PfSir2
(Fig. 4A, top panel). Next we used anti-PfHsp70-1 (Mattei
et al., 1989) as a cytoplasmic marker and observed a
colocalization with PfSUMO (Fig. 4A, middle panel). To
further investigate the observed extra parasitic host
cytosolic staining, we used a marker that stains the
P. falciparum Maurer’s clefts, mAb51-22 (Hinterberg et al.,
1994). We observed complete colocalization of the
Fig. 2. Immunoblot analysis with anti-PfSUMO and anti-FLAG antibodies. Total parasite extracts from mid to late trophozoites (30–32 h
post invasion) of 3D7 and 3D7 PfSUMO-FLAG tag expressing parasites were separated by 4–12% SDS-PAGE and immunoblotted with
anti-PfSUMO pre-immune, anti-PfSUMO sera and anti-FLAG antibodies. Arrows indicate multiple bands corresponding to probable SUMO
substrates identiﬁed in 3D7 and PfSUMO tagged parasite extracts by anti-PfSUMO and anti-FLAG antibodies respectively. Extracts from
uninfected red blood cells were separated by 4–12% SDS-PAGE and immunoblotted with anti-PfSUMO pre-immune, anti-PfSUMO sera and
anti-FLAG antibodies.
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bottom panel). These assays documented the presence
of putatively sumoylated proteins in different parasitic and
extra parasitic compartments (Fig. 4B).
To test for speciﬁcity of the PfSUMO serum antibodies,
we performed peptide competition assays and subse-
quent immunoﬂuorescence. The speciﬁc staining pattern
in the parasite and host cell could be inhibited in a dose-
dependent manner conferring that the IF staining is spe-
ciﬁc (Fig. S2). IFAs were also carried out with non-ﬁxed,
air-dried parasites and identical results obtained (data not
shown).
Fig. 3. PfSUMO immunoﬂuorescence assays throughout the blood stage cycle.
A. Reactivity of anti-PfSUMO sera on wild-type 3D7 strain parasites.
B. Reactivity of anti-FLAG (tag) antibody on PfSUMO-FLAG-tagged parasites. Ring stage 10–14 h, trophozoite stage 26–30 h, schizont stage
40–46 h post invasion.
C. Comparison of IFA pattern obtained by anti-PfSUMO and anti-FLAG antibodies on PfSUMO-FLAG-tagged parasites (trophozoites). Size bar
corresponds to 1 mm. Nuclear staining by DAPI in blue.
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PfSir2 is a nuclear plasmodial protein that is implicated in
control of var gene transcription (Duraisingh et al., 2005;
Freitas-Junior et al., 2005). During characterization of
this protein we observed a discrepancy from the pre-
dicted molecular weight of 30 kDa and instead observed
a major band of approximately 72 kDa on immunoblot-
A
B
Fig. 4. Distinct subcellular localization of PfSUMO conjugated proteins.
A. Co-localization assays of PfSUMO antiserum with nuclear marker PfSir2, cytoplasmic marker, PfHsp70-1 and Maurer’s clefts marker, Pf332
reveal compartmentalization. Size bar corresponds to 1 mm.
B. Schematic. Underlined compartments have been shown to react with anti-PfSUMO antibodies. In the nucleus, PfSir2 has been identiﬁed, in
this work, as the ﬁrst putative SUMO target in P. falciparum.
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questioned whether this shift in size could be due to a
post-translational modiﬁcation like sumoylation. On scan-
ning the PfSir2 for probable sumoylation motifs (Rod-
riguez et al., 2001), a consensus sequence of four amino
acids, most widely validated as SUMO binding motif (y K
x E/D), we found three motifs, one with high probability
and two with low probability that were potential SUMO
binding sites (http://www.abgent.com/doc/sumoplot,
Fig. 5A). Following this we carried out immunoprecipita-
tion (IP) assays with anti-PfSir2 and anti-PfSUMO anti-
bodies and probed the precipitated fractions with anti-
PfSUMO and anti-PfSir2 sera respectively (Fig. 5B and
C). The fraction immunoprecipitated with anti-PfSUMO
(Fig. 5B) recognized a faint yet distinct band at around
72 kDa on being probed with anti-PfSir2 along with a
fainter fraction at around 60 kDa. The same fraction
when blotted with PfSUMO as positive control recog-
nized many proteins, as can be deduced from the
multiple bands obtained. The control antibodies, namely
PfSUMO pre-immune and IgG (as control for rabbit sera
of PfSir2), did not reveal any of the above-mentioned
speciﬁc bands. We repeated this using PfSir2 for immu-
noprecipitation and probing with PfSUMO and obtained
corresponding results (Fig. 5C), thus ascertaining modi-
ﬁcation of PfSir2.
Fig. 5. Immunoblot analysis of immunoprecipitated PfSir2 and sumoylated proteins.
A. Sequence of PfSir2 obtained from PlasmoDB tested on SUMOplot to scan for potential SUMO acceptor motifs (y K x E/D, with y –a
hydrophobic residue, K – acceptor lysine to which the di-glycine motif of the SUMO peptide is attached, x – any amino acid followed by a
Glutamic acid or Aspartic acid). Coloured amino acids depict probable motifs with red depicting high probability motif and blue lower
probability, critical lysine residue with the motif is underlined.
B. Proteins immunoprecipitated from nuclear extracts with anti-PfSUMO sera were run on a 4–12% gradient gel and immunoblotted with
anti-PfSUMO sera and pre-immune sera as positive controls (ﬁrst two lanes), anti-PfSir2 (third lane) and anti-IgG (fourth lane). Arrow marks
corresponding PfSir2 band(s) observed in anti-PfSUMO immunoprecipitated protein extract.
C. Proteins immunoprecipitated with anti-PfSir2 sera were run on a 4–12% gradient gel and immunoblotted with anti-PfSir2 sera and anti-IgG
as positive controls (ﬁrst two lanes), anti-PfSUMO (third lane) and anti-PfSUMO pre-immune sera (fourth lane). Arrow marks corresponding
sumoylated fraction observed in anti-PfSir2 immunoprecipitated protein(s).
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by liquid chromatography-tandem mass spectrometry
LC-MS/MS (LTQ)
Sumoylation is a global modiﬁcation with widespread
targets and far-reaching effects. We were interested in
generating a ﬁrst list of putative SUMO targets in
P. falciparum to gain insight into the cellular processes
affected by this modiﬁcation. Taking advantage of the
FLAG-tagged PfSUMO strain, we conducted a two-step
puriﬁcation of SUMO target proteins. IPs were carried out,
ﬁrst with monoclonal anti-FLAG antibody followed by
anti-PfSUMO sera, thus increasing the stringency of the
puriﬁcation. Accurate mass (MS) and sequence informa-
tion (MS/MS) was obtained by standard in-gel trypsin
digestion of bands speciﬁc only to PfSUMO sera and
treatment of resulting eluates in the mass spectrometer.
Information acquired was used to identify the peptides
against the Plasmodium database using SEQUEST
algorithm. A list of corresponding proteins was generated
based on the analysis (Table 1).Although a number of hits
were obtained using stringent ﬁltering criteria, only a frac-
tion was identiﬁed by two or more peptides generating
more conﬁdence than those identiﬁed by single peptides.
This is not surprising, considering the reported low abun-
dance of sumoylated proteins at a given time in analogous
systems. It is noteworthy though that among all the sub-
strates recognized, a good number had orthologues
known to be sumoylated individually and/or as part of a
complex in other model systems (marked by asterisk ‘*’ in
Table 1). All the identiﬁed proteins harbour potential
sumoylation motifs (data not shown), though due to the
limitation of the mass spec technique, the exact residue(s)
could not be identiﬁed.
Discussion
In this work we present, for the ﬁrst time, experimental
evidence that P. falciparum utilizes SUMO conjugation to
modify blood stage proteins. Antibodies raised against a
P. falciparum SUMO peptide orthologue as well as against
Table 1. Putative SUMO substrates identiﬁed by LC-MS/MS analysis of Plasmodium falciparum proteins.
Gene ID
a Protein name Putative function Location
No. of
peptides
Proteins identiﬁed as sumoylation substrates by two or more peptides
PFD0415c Hypothetical Protein ND ND 6
Hypothetical Protein ND ND 6
PFC0140c N-ethylmaleimide-sensitive fusion protein, putative Vesicular trafficking IE
cytoplasmic
vesicular
structures
6
PF14_0326* Dynein-related AAA-type ATPase Invasion Merozoite 5
PFL1525c* Pre-mRNA splicing factor RNA helicase, putative Splicing ND 3
PF14_0314 Chromatin assembly factor 1 p55 subunit Transcription factor ND 2
PF14_0348 ATP-dependent Clp protease proteolytic subunit, putative ND ND 2
PF10_0161 PHIST domain protein ND ND 2
Proteins identiﬁed as sumoylation substrates by single peptide
PF11_0061* Histone H4 Chromatin structure ND
PF14_0334 NAD(P)H-dependent glutamate synthase, putative Glutamate metabolism ND
PFD0735c Hypothetical Protein ND ND
PF07_0030 Heat shock protein 86 family Heat shock protein ND
PFL0120c* Cyclophilin, putative Intracellular protein folding
and signal transduction
ND
PF11_0381 Subtilisin-like protease2 Invasion Micronemes
PF10_0055 Hypothetical Protein ND ND
PFE1120w Hypothetical Protein ND ND
PF11_0404* Transcription factor with AP2 domain(s) Transcription factor ND
PF14_0067 LCCL domain-containing protein CCP3 ND ND
PF14_0713 RNA-binding protein/splicing factor RNA binding/splicing ND
MAL7P1.68 Zinc ﬁnger containing ERF2 subunit of a palmitoyltransferase Palmitoylation ND
MAL8P1.7 DNA-directed RNA polymerase II second largest subunit,
putative
Transcription ND
PFF0975c Conserved plasmodium protein ND ND
PFF1440w* SETdomain protein Chromatin structure ND
PF10_0368* Dynamin protein Trafficking/organelle ﬁssion/
Cytoplasm, ER -Golgi,
Apicoplast
a. http://plasmodb.org
*Orthologues known to be directly sumoylated and/or part of sumoylated complex.
ND, not determined; IE, infected erythrocyte.
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blot, more than a dozen parasite proteins expressed
during the intracellular blood stage cycle. Many proteins
seen in total parasite extracts are also detected in nuclear
extracts (Figs 2A and 5A), indicating that the majority of
sumoylated proteins reside in the nucleus. Unlike ubiquiti-
nation, SUMO conjugated proteins are not marked
for degradation, but rather have a number of eclectic
functions in eukaryotic organisms such as in protein–
DNA interactions (Goodson et al., 2001; Hong et al.,
2001), regulation of transcription factor and chromatin-
remodelling protein(s) (Gill, 2003) among many other bio-
logical processes.Aknowledge of the proteins targeted by
this modiﬁcation is thus of utmost importance in decipher-
ing its impact on the biology of the organism. To this end,
we have also generated the ﬁrst list of candidate-
sumoylated proteins in plasmodium by mass spectrom-
etry approach. Some of these are of particular interest for
the parasite biology (Table 1) and may be pursued for
further investigation. Given the limiting amount of plasmo-
dial extracts obtainable as compared with other model
organisms (i.e. yeast, mammalian) as also the low abun-
dance of enriched SUMO conjugates present at a given
time, identiﬁcation of sumoylated targets is technically
challenging and requires an upscaling of the initial starting
material and more sensitive instrumentation.
The staining of anti-PfSUMO with Maurer’s clefts indi-
cates that the parasite may traffic SUMO-conjugated pro-
teins outside the conventional intracellular compartments
into the erythrocyte cytoplasm (see Fig. 4B). The robust
appearance of an NSF fusion protein in the mass spec
analysis complements this observation (Table 1). This
protein is known to appear as cytoplasmic vesicular struc-
tures with putative role in vesicular trafficking (Hayashi
et al., 2001). Combining these observations, it is tempting
to speculate that PfSUMO may take part in the regulation
of virulence factor trafficking to the infected erythrocyte
(IE) surface, as has been described for another post-
translational modiﬁcation, the phosphorylation of Maurer’s
clefts proteins by parasite exported kinases (Droucheau
et al., 2004; Nunes et al., 2007). Our efforts to identify
sumoylated proteins in puriﬁed ghosts of IE failed using
our anti-PfSUMO antibodies (data not shown). This may
be due to the low abundance of proteins that carry this
modiﬁcation. In FLAG-tagged parasites, only a minor frac-
tion of the IE cytoplasm was stained, indicating that the
pathway leading to the Maurer’s clefts trafficking may be
disturbed by the presence of the FLAG tag.
Having observed the unusual molecular weight of the
nuclear protein PfSir2 in Western blot in nuclear extracts,
we speculated that it may be a substrate for SUMO
ligase(s). The open reading frame predicts a protein of
approximately 30 kDa and the apparent MW is 72 kDa
using a number of different anti-PfSir2 antibodies (Freitas-
Junior et al., 2005). Given that three putative sumoylation
sites are found in the PfSir2 sequence (Fig. 5A), full
sumoylation would predict a molecule of approximately
70 kDa. Our data strongly support SUMO conjugation
causing the increase in molecular weight of PfSir2. The
fainter band at approximately 52 kDa (Fig. 5B) could
be either a differentially spliced form or a degradation
product. PfSir2 is known to be associated with the nuclear
periphery with telomeres and nucleolus. We hypothesize
that PfSir2 sumoylation determines the nuclear location of
PfSir2. Mutant PfSir2 revealed in P. falciparum that this
protein is involved in a number of different functions, such
as gene silencing of a subgroup of telomere-adjacent var
genes (Duraisingh et al., 2005; Freitas-Junior et al., 2005)
and telomere length control (A. Scherf, unpubl. data).
Work to investigate whether mutating the three putative
SUMO conjugation sites may lead to differential subcel-
lular location of PfSir2, or alter var gene de-repression
and telomere length, is underway. The yeast Sir2 is
not sumoylated (Denison et al., 2005). However, other
HDACs have been shown to be sumoylated (David et al.,
2002; Cheng et al., 2004) with altered biological activity
in terms of levels of protein acetylation and/or gene
repression. Interestingly, very recent studies show SIRT1,
the closest mammalian homologue of yeast Sir2, to be
sumoylated thereby increasing its deacetylation activity
(Yang et al., 2007).
Histone sumoylation in S. cerevisiae has been recently
observed, implicating it as an alternative mechanism akin
to other chromatin modiﬁcations, such as methylation and
acetylation (Nathan et al., 2006). We investigated whether
P. falciparum histones carry SUMO marks. Histone H4
speciﬁcally came up as a SUMO substrate in our mass
spec analysis (Table 1). Using semi-puriﬁed histones and
reacting with anti-PfSUMO sera, we observed a faint band
migrating higher than the predicted molecular weight of
histones (this work, unpublished data). Also, this obser-
vation is compatible with a minor fraction of histones
being conjugated to SUMO and argues for a possible
role of sumoylation as a negative regulator in malaria
parasites. Interestingly, the H2AZ homologue seemed to
accumulate as many as six potential SUMO motifs in the
N-terminal region (H2AZ – 6 sites – K11, K15, K25, K30,
K38, K153; H2A – 4 sites K6, K21, K36 and K124), out-
numbering those present in yeast H2AZ and H2A. Similar
tandem array of potential sumoylation sites in the
N-terminal region were also seen on other apicomplex-
ans, e.g. the T. gondi H2AZ (with seven motifs in the
N-terminal). Given the exposure of the N-terminal region
of histones to enzymatic modiﬁcations, it points to a pos-
sible differential utilization of the same lysine residues for
different modiﬁcations.
Stabilizing proteins by competing with ubiquitin
(Desterro et al., 1998) and regulation of binding to
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mechanisms known to be associated with SUMO modiﬁ-
cation of transcription factors, strictly limiting it to target-
SUMO covalent conjugation. Recently, though SUMO has
been suggested to have a transcriptionally repressive
role, mainly by promoting non-covalent interactions with
co-repressors. Multitude of chromatin (histone) modifying
enzymes, including deacetylases, methyltranferases and
demethylases, are proposed to be among the many tran-
scriptional regulators that interact non-covalently with
SUMO to bring about repression (Yang et al., 2003;
Rosendorff et al., 2006). In line with this, a number of
putative sumoylated proteins identiﬁed in our mass spec
study are potential transcription and chromatin regulators
and orthologues of some of those identiﬁed are known
SUMO targets (Table 1). The proteins detected in our
analysis are probably only the most dominant ones and
represent only ‘the tip of the iceberg’. Nonetheless, iden-
tiﬁcation of SUMO – interacting domains on these and
other potential candidates will be of utmost importance.
Moreover, the physical association of SUMO with large
multiprotein complexes like nuclear lamin proteins, PML
nuclear bodies and centromeres may suggest SUMO in
maintaining stability of multiprotein complexes (Zhong
et al., 2000; Seeler et al., 2001), an interesting avenue to
explore in a system like Plasmodium where multiprotein
complexes are known to work in tandem for important
processes like trafficking and silencing, etc.
In summary, despite the growing knowledge on the
importance of this relatively novel modiﬁcation, little is
known about its precise biological impact/outcome even
in extensively studied model systems, and none in api-
complexan before this study. The list of newly discovered
SUMO substrates is expanding only recently in other
model systems whereas none existed so far for plasmo-
dium before this study. No unifying role could be so far
associated with sumoylation in eukaryotes and it appears
that each studied class of protein adds a new function to
the long list of described biological roles (Seeler et al.,
2007; Xhemalce et al., 2007). Our work on malaria para-
sites supports this notion, as we observe sumoylation of
the telomere-associated protein PfSir2, involved in gene
silencing, and we present evidence of a putative SUMO
substrate that is exported from the parasite into the host
cytoplasm via Maurer’s clefts. Both observations have not
been previously associated with SUMO and support the
notion in malaria parasites of ‘The usual suspect in a new
scenario’. Obviously, a ﬁrst logical step would be to do an
in-depth and detailed proteomic proﬁle of the same to
identify more SUMO substrates in blood stage parasites
of P. falciparum and identify their critical role in the biology
of the parasite such as immune escape, invasion process
and gene regulation. Both Plasmodium-speciﬁc anti-
PfSUMO antibody and the FLAG-tagged SUMO strain
generated in our work provide a valuable tool to explore
the biological impact of this modiﬁcation in the pathogen.
The list of putative plasmodial SUMO substrates further
provides direction to this understanding.
Experimental procedures
P. falciparum cultures
Plasmodium falciparum blood stage parasites from the 3D7 strain
were cultured using modiﬁcations to the method described by
Trager and Jensen (1976). Brieﬂy, parasites were grown in
O+ human erythrocytes in RPMI 1640 medium containing
L-glutamine (Invitrogen) supplemented with 5% v/v human AB
serum (PAA Laboratories GmbH) and 5% v/v Albumax II
(Invitrogen) in a gas environment of 5% CO2,1 %O 2 and 94% N2.
Cultures were synchronized with two consecutive 5% sorbitol
(Sigma) treatments (Lambros and Vanderberg, 1979). For kinetic
IFAs the parasites were synchronized within a window of approxi-
mately 6 h, monitored by Giemsa staining.
Bioinformatic analysis
Genes coding for putative ubiquitin-like proteins in P. falciparum
were obtained both from PlasmoDB (http://www.plasmodb.org)
and GeneDB (http://www.genedb.org/genedb/malaria/). To iden-
tify the plasmodial SUMO gene (PfSUMO), previously character-
ized yeast SUMO/SMT3 orthologues (YDR510W) were obtained
from NCBI (http://www.ncbi.nlm.nih.gov/BLAST/) and used as
query on TBLASTN. Multiple sequence alignments were con-
structed using CLUSTALW algorithm using the BLOSUM series
of similarity matrix with gap opening and extension penalties of
10 and 0.1 respectively.
Antibodies
To obtain polyclonal antibody serum against PFE0285c
(PfSUMO1), we used the Eurogentec standard protocols (http://
www.eurogentec.com) for immunizing guinea pigs and mice.
Each animal was immunized with a combination of two synthetic
peptides. The peptide sequences are as follows: H2N-
[+C]QGEHIQVKVRSPDGA-CONH2 and H2N-[ + C]YDGDRIHG
DNTPEQL. BLAST search using individual peptide sequence(s)
against the P. falciparum database did not yield any signiﬁcant
hits. Anti-FLAG mouse monoclonal antibody was obtained from
Sigma. Co-localization assays were carried out with antibodies
directed against speciﬁc markers: nuclear marker, PfSir2
(Freitas-Junior et al., 2005), parasite cytoplasmic marker,
PfHsp70-1 (Mattei et al., 1989) and Maurer’s clefts marker,
mAb51-22 (anti-Pf332) (Hinterberg et al., 1994).
Plasmid construct and parasite transfection
PfSUMO gene was ampliﬁed using Expand High Fidelity PCR
System (Roche) with primers containing restriction sites for the
enzymes XhoI and AﬂII, forward primer 5′-CCGCTCGAG
ATGGGAGATGACGATTCAGC-3′, reverse primer 5′-AAAAAA
CTTAAGTTAGAAACTTCCTCCTGTTTGCTGAACC-3′ (enzyme
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1¥ FLAG tag previously cloned into the backbone plasmid vector
pLN-ENR-GFP (Nkrumah et al., 2006). 3D7 ring stage parasites
were transfected by electroporation and drug selected using
bacterial integrase mediated transfection system as previously
described (Nkrumah et al., 2006) to obtain chromosomal integra-
tion of the tagged construct.
Immunoﬂuorescence microscopy
Synchronized IEs (ring stage 10–14 h, trophozoite stage
26–30 h, schizont stage 40–46 h) were washed in phosphate-
buffered saline (PBS) (0.15 M NaCl and 10 mM sodium phos-
phate, pH 7.2). Cell pellets were re-suspended in 5 vols of PBS
and a monolayer was set onto microscope slides. Parasites were
air-dried and ﬁxed for 10 min at room temperature in 4%
paraformaldehyde. Slides were blocked for 20 min in 0.1%
bovine serum albumin (BSA) and incubated with the primary
antibody diluted in 0.1% BSA for 45 min at room temperature.
After washing, cells were incubated for 30 min with a secondary
antibody conjugated with appropriate ﬂuorochrome (Alexa Fluor
488, Alexa Fluor 568, Molecular Probes) in a 1:500 dilution.
Slides were washed thoroughly in PBS and mounted in Vectash-
ield anti-fading containing 4-6-diamidino-2-phenylindole (DAPI)
for nuclear staining (Vector Laboratories). Images were captured
using a Nikon Elipse 80i optical microscope.
Anti-PfSUMO sera were pre-absorbed with lysed erythrocytes
before incubation with the IEs. The ﬁnal antibody dilutions were
1:200 for both PfSUMO sera and pre-immune, 1:500 for anti-
FLAG, 1:100 for anti-PfSir2, 1:500 for anti-PfHsp70-1 and 1:400
for anti-mAb51-22 for colocalization assays.
Peptide competition assays were performed to test the speci-
ﬁcity of the anti-PfSUMO sera. Increasing concentrations of the
speciﬁc and unspeciﬁc peptides, respectively (ranging from 3 mg
of respective peptide per ml to 3000 mg per ml), were added to
the serum and incubated overnight in a rotating wheel at 4°C. The
serum was subsequently used to carry out IFA as described
above.
Western blot analysis
Equal amounts of parasite protein extracts from 3D7 strain and
PfSUMO-FLAG transfected strain were separated by 4–12%
SDS-PAGE on gradient gels (Invitrogen) and transferred onto
nitrocellulose membranes. Membranes were blocked at room
temperature for 1 h in PBS, 0.05% Tween-20 and 5% non-fat milk
and probed with antibody against PfSUMO and pre-immune
sera overnight at 4°C. Secondary antibodies conjugated to
horseradish peroxidase (Pierce) were incubated for 1 h at room
temperature and developed with SuperSignal West Pico
Chemiluminescent Substrate (Pierce) according to the manufac-
turer’s instructions. Precision Plus Pre-stained molecular weight
marker was obtained from Bio-Rad.
Immunoprecipitation assays
Brieﬂy, ~4 ¥ 10
7 parasites (trophozoite stage 26–30 h post inva-
sion) were isolated from IE by saponin lysis. Parasites were
re-suspended in Lysis buffer [10 mM Hepes (pH 7.9), 10 mM
KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, 0.25% NP-40]
containing a mixture of protease inhibitors (Roche) and set on ice
for 30–60 min. Parasites were then lysed by 100–300 strokes
in a homogenizer, the nuclei recovered by centrifugation,
re-suspended in 100 ml of sonication buffer and then incubated
on ice for 15 min followed by sonication with a Bioruptor Sonica-
tor according to manufacturer’s instructions. After sonication-
insoluble material was removed by centrifugation, lysates were
pre-cleared by incubation with proteinAsepharose CL-4B (Amer-
sham) for 1 h. The extracts were incubated overnight at 4°C with
15 ml each of PfSUMO antisera and the pre-immune serum,
anti-PfSir2 and anti-IgG. Immunoprecipitates were collected with
protein A sepharose, and washed once each with low-salt wash
buffer [0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl
(pH 8.1), 150 mM NaCl, protease inhibitors], High-salt wash
buffer [0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl
(pH 8.1), 500 mM NaCl, protease inhibitors] and LiCl-immune
complex wash buffer (0.25 M LiCl, 1% NP-40, 1% deoxycholate,
1 mM EDTA, 10 mM Tris-HCl [pH 8.1], protease inhibitors) fol-
lowed by a wash in TE buffer. The immunoprecipitated proteins
were eluted from the sepharose beads by addition of Lamelli
buffer and boiling for 10 min at 95°C. The eluates were separated
on 4–12% SDS gels and blotted with appropriate antibodies as
described above.
Mass spectrometry analysis
Two-step IPs were performed, as above, on extracts from asyn-
chronous blood stage cultures of PfSUMO-FLAG transfected
strain. Monoclonal anti-FLAG antibody was used in the ﬁrst step
IP and eluate was subjected to second IP with anti-PfSUMO and
pre-immune sera respectively.After standard in-gel trypsin diges-
tion, samples were subjected to MS/MS spectrometry using a
LTQ ion trap mass spectrometer. The collection of resulting
spectra was then searched against a plasmodium database
(PlasmoDB) using the SEQUEST algorithm. Pepetides identiﬁed
were subjected to stringent search criteria with Xcorr values
greater than 1.9, 2.2, 3.75 and 4.5 for 1, 2, 3 and 4 spectra,
respectively, and Delta CN > 0.1.
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Supplementary material
The following supplementary material is available for this article
online:
Fig. S1. PfSUMO versus ubiquitin alignment. CLUSTAL W algo-
rithm was used to ascertain PfSUMO homology to known ubiq-
uitin and Ubl orthologues. Multiple alignment between human
ubiquitin and Nedd8, S. cerevisiae Ubiquitin and Nedd8-like
RUB1 and S. pombe Nedd8 was done. Dark shading represents
residues identical in all sequences. Light shading, residues
similar between respective sequnces. Box, conserved Lys 48 and
Lys 63, which serve as common sites of ubiquitination polymer-
ization, which are missing in PfSUMO sequence, as pointed with
arrow(s).
Fig. S2. PfSUMO peptide competition assay. IFA after compet-
ing PfSUMO antisera with PfSUMO peptide (A) and unspeciﬁc
peptide (B). Horizontal grey bar above IFA panel depicts increas-
ing amount of speciﬁc and unspeciﬁc peptide used, respectively,
to compete the antisera (3–3000 mgm l
-1).
This material is available as part of the online article from:
http://www.blackwell-synergy.com/doi/abs/10.1111/
j.1462-5822.2008.01183.x
Please note: Blackwell Publishing is not responsible for the
content or functionality of any supplementary materials supplied
by the authors. Any queries (other than missing material) should
be directed to the corresponding author for the article.
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